SCHEMBL6100481

SCHEMBL6100481

CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(O)n1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLCO1B1 Q9Y6L6 4/20 0.45
ABCB11 O95342 3/20 0.45
HMGCR P04035 3/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC2 Q92769 2/20 0.45
HDAC6 Q9UBN7 2/20 0.45
NR1I2 O75469 1/20 0.45
RHOC P08134 1/20 0.45
CYP3A4 P08684 1/20 0.45
THRB P10828 1/20 0.45
NR1H4 Q96RI1 1/20 0.45
ABCG2 Q9UNQ0 1/20 0.45
ABCC3 O15438 2/20 0.43
ABCC4 O15439 2/20 0.43
SLCO1B3 Q9NPD5 2/20 0.43
BCL2 P10415 1/20 0.43
GAA P10253 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 1/20 0.41
UBE2N P61088 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21637568 0.86 SLCO1B1 (0.52) SLCO1B1ABCB11HMGCRHDAC1HDAC2
SCHEMBL28861773 0.83 BCL2 (0.45) SLCO1B1ABCB11HMGCRHDAC1HDAC2
SCHEMBL21637575 0.80 HMGCR (0.61) SLCO1B1ABCB11HMGCRHDAC1HDAC2
SCHEMBL21637567 0.79 HMGCR (0.60) SLCO1B1ABCB11HMGCRHDAC1HDAC2
SCHEMBL4433488 0.74 HMGCR (0.49) SLCO1B1ABCB11HMGCRHDAC1HDAC2
SCHEMBL29795041 0.74 SLCO1B1 (0.51) SLCO1B1ABCB11HMGCRHDAC1HDAC2
Calcium SCHEMBL4738406 0.74 HMGCR (0.48) SLCO1B1ABCB11HMGCRHDAC1HDAC2
SCHEMBL14026658 0.74 SLCO1B1 (0.52) SLCO1B1ABCB11HMGCRHDAC1HDAC2
SCHEMBL5809084 0.73 SLCO1B1 (0.49) SLCO1B1ABCB11HMGCRHDAC1HDAC2
SCHEMBL6871693 0.73 HMGCR (0.64) SLCO1B1ABCB11HMGCRHDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108373437-A A kind of preparation method of Atorvastatin calcium isomers 扬子江药业集团江苏海慈生物药业有限公司 2018-08-07 CN claimed
CN-108558726-A A kind of preparation method of high purity atorvastatin calcium 湖北广济药业股份有限公司 2018-09-21 CN disclosed
CN-108373437-A A kind of preparation method of Atorvastatin calcium isomers 扬子江药业集团江苏海慈生物药业有限公司 2018-08-07 CN disclosed
CN-106471119-A Compositions and methods for increasing yield 诺华股份有限公司 2017-03-01 CN disclosed
WO-2006011041-A3 CRYSTALLINE FORMS OF (R-(R*))-2-(4-FLUOROPHENYL)-BETA, GAMMA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-((PHENYLAMINO)CARBONYL)-1H-PYRROLE-1-HEPT ANOIC ACID CALCIUM SALT (2:1) WARNER LAMBERT CO (US) 2006-06-22 WO disclosed
WO-2006011041-A2 CRYSTALLINE FORMS OF (R-(R*))-2-(4-FLUOROPHENYL)-BETA, GAMMA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-((PHENYLAMINO)CARBONYL)-1H-PYRROLE-1-HEPT ANOIC ACID CALCIUM SALT (2:1) WARNER-LAMBERT COMPANY LLC (US) 2006-02-02 WO disclosed